Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
LSE:CREO
Price:
14.125
GBX
Market Closed
Market Cap:
£58.3m
Wall Street
Price Targets
CREO Price Targets Summary
Creo Medical Group PLC
Creo Medical Group PLC
Wall Street analysts forecast CREO stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
CREO
is 56.1 GBX
with a low forecast of 40.4 GBX and a high forecast of 73.5 GBX.
Lowest
Price Target
40.4
GBX
186% Upside
Average
Price Target
56.1
GBX
297% Upside
Highest
Price Target
73.5
GBX
420% Upside
Creo Medical Group PLC Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CREO's stock price target?
Price Target
56.1
GBX
56.1
GBX
According to Wall Street analysts, the average 1-year price target for
CREO
is 56.1 GBX
with a low forecast of 40.4 GBX and a high forecast of 73.5 GBX.
What is Creo Medical Group PLC's Revenue forecast?
Projected CAGR
69%
69%
The
compound annual growth rate
of Creo Medical Group PLC's revenue for the next 4 years is
69%.
